End-stage Renal Disease Costs for Patients New to Hemodialysis in Italy: The FARO-2 Study
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 12, Issue 5
Abstract
Background: Increasing incidence and prevalence of end-stage renal disease (ESRD) together with the presence of several comorbidities in chronic kidney disease patients (CKD) could be associated with a relevant economic burden. Aim: The aim of this analysis was to estimate the direct healthcare costs of ESRD and its major comorbidities in Italian patients who were naïve to hemodialysis (HD) recruited for the FARO-2 study. Methods: The FARO-2 study was a retrospective observational study conducted in Italy that evaluated the patterns of treatment of secondary hyperparathyroidism (SHPT) and related costs in patients naïve to HD. The observational period was 2006–2008. Costs were measured in Euros (reference year: 2008). Resource use for the first 2 periods of 6 months of HD was monetized, with reimbursement calculated for SHPT drugs, phosphate binders, and erythropoietin-stimulating agents (ESAs); HD sessions; and hospitalizations due to ESRD and its major comorbidities. The analysis was performed by the Italian National Health Service (INHS) perspective. Results: 567 patients were observed for at least 2 periods of 6 months. During the first 12 months after the initiation of HD, average direct healthcare costs were assessed using the percentage of patients treated and the average daily dosages (for drugs), the percentage of patients hospitalized and the types of hospitalizations (for inpatients), and the average weekly frequency of HD sessions. Total per-patient yearly costs totaled 34,789.9 €: HD accounted for 66.1% of expenditures, with hospitalizations and drugs accounting for 12.9% and 21.0% of expenditures, respectively (including 17.1% for ESAs). Conclusions: Patients naïve to HD have a significant impact on Italian National Health Service expenditures, although only the costs related to treatment of ESRD and its comorbidities were calculated in the present study. The major cost drivers were HD and ESAs, while SHPT drugs and phosphate binders together accounted for only 3.9% of direct healthcare expenditures.
Authors and Affiliations
Daniela Paola Roggeri, Alessandro Roggeri, Diego Brancaccio, Sandro Mazzaferro, Piergiorgio Messa, Ernesto Paoletti, Anna Maria Costanzo, Umberto di Luzio Paparatti, Mario Cozzolino
Keywords
Related Articles
- EP ID EP340497
- DOI 10.9734/BJMMR/2016/22222
- Views 73
- Downloads 0
Harlequin Ichthyosis: Case Report of a Rare Type of Ichthyosis
Aims: The purpose of this study is to present a case of Harlequin fetus, which is extremely rare. Presentation of Case: A 27-year-old woman, gravida 3 para 1, was referred to the clinic with a diagnosis of preterm premat...
Open (Miligan Morgan) Haemorrhoidectomy versus Stapled Haemorrhoidopexy: A Comparative Study
Background: Haemorrhoidal disease, one of the most common anorectal disorders, when complicated, is a painful concern to the patient. Miligan Morgan haemorrhoidectomy is a commonly performed gold standard procedure for h...
Analysis of Undergraduate Students’ Perception of the Educational Environment of a Medical School in Zambia Provided a Framework for Strategic Planning
Aim: To propose a strategy for improvement of undergraduate students’ learning environment based on analysis of their perceptions. Methods: Medical, Pharmacy, and Physiotherapy undergraduate students participated in the...
Odontogenic Myxoma of Mandible Appeared as an Ameloblastoma on CT Imaging
Odontogenic myxoma is a rare benign tumor of ectomesenchymal origin, which can arise from dental papilla, follicle or periodontal ligament. Most commonly it arises from mandible followed by maxilla. We report a case of o...
Reversible Acute Renal Failure in a Elderly Patient with Minimal Change Disease: A Case Report
Introduction: Minimal change disease is a histopathological lesion of the kidneys most commonly associated with nephrotic syndrome. Three pathophysiological mechanisms have been proposed to explain this syndrome: Nephros...